Raloxifene HCL Precautions, Details, Emergency, warnings, Fda, api, Active Pharmaceutical Ingredients, Symptoms, Exporters, hydrochloride, Causes, Health Centres, Importers, Generic Products, bulk drugs, Raw Material Exporters, Molecular Formula C28H27NO4S.HCl;C28H28ClNO4S, Molecular Weight 510.05, CAS Registry Number 82640-04-8, Research, Taj Pharmaceuticals LTd.

Sitemap | Contact Us

Welcome To Taj Pharmaceuticals Ltd API

© 2004 - 2019 Taj Pharmaceuticals Limited . All rights reserved

Raloxifene Hcl Taj Pharmaceticals Ltd.

India

Latin America/ Caribbean

Africa & Middle East

Asia

Russia

Europe

Raloxifene Hcl Manufacturers in India Suppliers Raloxifene Hcl Exporters Distributors Raloxifene Hcl api active pharmaceuticals ingredients Raloxifene Hcl manufacturers Side Effects bulk drugs raw material Raloxifene Hcl companies Side Effects Importers Raloxifene Hcl Raloxifene Hcl Exporters Raloxifene Hcl exporters FDA Raloxifene Hcl DMF Symptoms Generic Taj Pharmaceuticals Ltd.

active pharmaceutical ingredients suppliers pharmaceutical Raloxifene hydrochloric manufacturing pharmaceutical drugs pharmaceutical intermediates Raloxifene hydrochloric pharmaceutical chemicals pharmaceutical raw materials Raloxifene hydrochloric active pharmaceutical ingredients Raloxifene hydrochloric committee active pharmaceutical ingredients manufacturer Raloxifene hydrochloric Active Pharmaceutical Ingredients manufacturer Raloxifene hydrochloric exporter drug ingredients pharmaceuticals

Pharmaceuticals API Manufacturer Raloxifene Hcl, Raloxifene Hcl manufacturer India, Raloxifene Hcl product, Raloxifene Hcl products, Api preparation, Certificate of Analysis API manufacturer product, Raloxifene Hcl anti ulcer product, Certificate of Origin COA Raloxifene Hcl COS Raloxifene Hcl, pharmaceutical generic, pharmaceutical drug, medical, Raloxifene Hcl pharma healthcare, pharma patents, contract MSDS manufacturing Trader Raloxifene Hcl pharma, generic pharma, HCL pharma MSDS pharmaceutical products, pharmaceutical formulations, generic import API, Raloxifene Hcl expectorant Pharmaceutical GMP Method of analysis formulations manufacturer, Raloxifene Hcl DMF drug master file pharmaceutical Anti Cancer active ingredient exporter from India, pharma Raloxifene Hcl ingredients, api, HIV Raloxifene Hcl, tablets, capsules, syrup & protein Raloxifene Hcl powder, GMP of Plant api nutraceuticals, gynec products, ortho ingredients in India, oncology products, Raloxifene Hcl gastroenterology products, buy, sell orthopaedic product, who gmp, cGMP, US FDA, Raloxifene Hcl WHO, UKMHRA Approval

	PRODUCT LIST
	Home
	API >>>
	Pharmaceuticals API List
	Chemicals
	Manufacturing
	Product Development
	Product Search
	Agro Chemicals
	Custom Pharma Services
	Contact Us

HOME >> API >> API List 3 >> Raloxifene Hcl >> Precautions

Raloxifene Hcl CAS Number 82640-04-8

PRECAUTIONS
Raloxifene Hcl CAS Number 82640-04-8

The medication can increase the risk of blood clots. You are at higher risk for blood clots if your mobility is limited due to surgery, bed rest, or traveling. In order to help prevent blood clots, raloxifene should be stopped at least three days before any surgery that will limit your mobility. While traveling, make sure that you try to move about periodically to keep the blood flowing through your legs. If you have a condition that may predispose you to blood clots (such as cancer or congestive heart failure), your healthcare provider should weigh the benefits of raloxifene against the risks of a blood clot. In one study of raloxifene in women with heart disease (or who were at high risk for heart problems), the medication increased the risk of death due to strokes. If you already have risk factors for a stroke (such as a prior stroke or mini-stroke, a heart arrhythmia, high blood pressure, or cigarette smoking), your healthcare provider should weigh the risk of a stroke against the benefits of raloxifene. Raloxifene should not be used to treat or prevent heart disease. Studies have shown that the drug is not effective for this use.

Raloxifene has not been adequately studied in premenopausal women or in men. Also, the medication has not been adequately studied in women who have already had breast cancer.

Some women have a tendency to develop high triglycerides while taking an estrogen medication. Even though raloxifene is not an estrogen medication, it can act like estrogen in some ways. The drug may cause high triglycerides, especially in women who have a history of high triglycerides due to estrogen.

Let your healthcare provider know if you have liver or kidney disease, as your body may not handle raloxifene as well as it should.
Raloxifene can potentially interact with a number of medications

Information Associated with Product:

DRUG DESCRIPTION

DOSAGE

SIDE EFFECTS

PRECAUTIONS >>

INTERACTION

CONSUMER INFORMATION

PDF DOWNLOAD

WORD DOCUMENT


Product Enquiry	Product Quotation	Sample Request	Place Your Order

Taj Pharmaceuticals API Logo

Investor Relations Feedback Contact Worldwide Sitemap

© 2004 - 2019 Taj Pharmaceuticals Limited . All rights reserved
Note:-We are committed to helping you find the right answers to your questions and concerns. However, this web site is not intended to give investment advice, promote the use of Taj Pharmaceuticals Limited products or provide information on which to base medical treatment. If you have questions regarding any Taj Pharmaceuticals Ltd product or are experiencing a medical emergency, please consult your health care provider.
Additionally, contact information on this web site cannot be used to report adverse drug events. If you are a physician, please follow the procedures required by your country's regulations. Please choose one of the given options to contact us and we will respond to your inquiry as quickly as possible.